- Home
- GSIW vs CMND Comparison
GSIW vs CMND Comparison
Compare GSIW & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSIW
- CMND
- Stock Information
- Founded
- GSIW 2016
- CMND 2017
- Country
- GSIW Hong Kong
- CMND Canada
- Employees
- GSIW N/A
- CMND N/A
- Industry
- GSIW
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- GSIW
- CMND Health Care
- Exchange
- GSIW Nasdaq
- CMND Nasdaq
- Market Cap
- GSIW 12.3M
- CMND 6.5M
- IPO Year
- GSIW 2023
- CMND N/A
- Fundamental
- Price
- GSIW $0.59
- CMND $1.42
- Analyst Decision
- GSIW
- CMND
- Analyst Count
- GSIW 0
- CMND 0
- Target Price
- GSIW N/A
- CMND N/A
- AVG Volume (30 Days)
- GSIW 11.3M
- CMND 113.9K
- Earning Date
- GSIW 12-31-2024
- CMND 01-22-2025
- Dividend Yield
- GSIW N/A
- CMND N/A
- EPS Growth
- GSIW N/A
- CMND N/A
- EPS
- GSIW N/A
- CMND N/A
- Revenue
- GSIW $1,313,795.00
- CMND N/A
- Revenue This Year
- GSIW N/A
- CMND N/A
- Revenue Next Year
- GSIW N/A
- CMND N/A
- P/E Ratio
- GSIW N/A
- CMND N/A
- Revenue Growth
- GSIW N/A
- CMND N/A
- 52 Week Low
- GSIW $0.43
- CMND $0.95
- 52 Week High
- GSIW $15.45
- CMND $2.30
- Technical
- Relative Strength Index (RSI)
- GSIW 49.76
- CMND 45.84
- Support Level
- GSIW $0.44
- CMND $1.35
- Resistance Level
- GSIW $1.25
- CMND $1.50
- Average True Range (ATR)
- GSIW 0.11
- CMND 0.09
- MACD
- GSIW 0.01
- CMND -0.01
- Stochastic Oscillator
- GSIW 18.62
- CMND 14.22
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.